Article Text

Unusual association of diseases/symptoms
Acquired von Willebrand syndrome in a 10-year-old girl with acute lymphoblastic leukaemia
  1. Isabel Dorn1,
  2. Ulrich Budde2,
  3. Michael C Frühwald3,
  4. Monika Pöppelmann3,
  5. Ulrike Nowak-Göttl3
  1. 1
    University Childrens’s Hospital Münster, General Pediatrics, Albert-Schweitzer-Strasse 33, Muenster, 48149, Germany
  2. 2
    Aesculabor Hamburg, Haferweg 36, Hamburg, 22769, Germany
  3. 3
    University Children’s Hospital Münster, Pediatric Hematology and Oncology, Albert-Schweitzer-Strasse 33, Muenster, 48149, Germany
  1. Isabel Dorn, Isabel.Dorn{at}


Following diagnosis of acute lymphoblastic leukaemia (ALL) in a 10-year-old girl, routine coagulation screening including von Willebrand factor antigen (VWF:Ag), ristocetin cofactor activity (VWF:RCo) and factor VIIIC (FVIII:C) detected no pathological findings. After the first HR2′ element of the high-risk group of the ALL-BFM 2000 protocol, the patient demonstrated extensive bleeding symptoms and acquired von Willebrand syndrome was diagnosed. VWF:Ag (13%), VWF:RCo (13%) and FVIII:C (27%) were decreased. Multimer analysis showed a loss of large multimers and a loss in triplet structures. The observed pattern was thought to be typical for monoclonal IgG gammopathy; however, in this case, unexpectedly, biclonal IgM gammopathy (κ and λ) was detected. After treatment with intravenous immunoglobulin over 5 days, coagulation factors increased to normal levels. Although this effect was assumed to be at best only temporary, especially in a case of IgM gammopathy, no further bleeding symptoms have been observed.

Trial registration number: M208

View Full Text

Statistics from


  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.